Response to: ‘Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al
Alexis Mathian, Zahir Amoura
Topics & Concepts
HydroxychloroquineMedicineRheumatologyCoronavirus disease 2019 (COVID-19)CoronavirusCohortInternal medicineIncidence (geometry)Cohort studyEpidemiologyDiseaseLupus erythematosusSystemic lupus erythematosusImmunologyInfectious disease (medical specialty)AntibodyPhysicsOpticsCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Systemic Lupus Erythematosus Research